ArticleBioconjugate chemistry2019

Human Vault Nanoparticle Targeted Delivery of Antiretroviral Drugs to Inhibit Human Immunodeficiency Virus Type 1 Infection.

Jennifer A Fulcher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.